Cargando…
Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity
Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose existing drugs against SARS-CoV-2. The general hypothesis of signature-based drug repurposing is that drugs with inverse similarity to...
Autores principales: | Barsi, Szilvia, Papp, Henrietta, Valdeolivas, Alberto, Tóth, Dániel J., Kuczmog, Anett, Madai, Mónika, Hunyady, László, Várnai, Péter, Saez-Rodriguez, Julio, Jakab, Ferenc, Szalai, Bence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022874/ https://www.ncbi.nlm.nih.gov/pubmed/35404937 http://dx.doi.org/10.1371/journal.pcbi.1010021 |
Ejemplares similares
-
An Unexpected Enzyme in Vascular Smooth Muscle Cells: Angiotensin II Upregulates Cholesterol-25-Hydroxylase Gene Expression
por: Kovács, Kinga Bernadett, et al.
Publicado: (2023) -
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue
por: Konrat, Robert, et al.
Publicado: (2022) -
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
por: Chuang, Sung-Ting, et al.
Publicado: (2022) -
Transactivation within the AT(1 )angiotensin receptor homodimer: the role of the conserved DRY motif
por: Szalai, Bence, et al.
Publicado: (2009) -
Modeling in systems biology: Causal understanding before prediction?
por: Barsi, Szilvia, et al.
Publicado: (2021)